EuroEyes International Eye Clinic Limited

As of December 31, 2025, EuroEyes International Eye Clinic Limited carries a market capitalization of 971.29M, placing it among publicly traded companies globally. Its enterprise value stands at 720.69M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

EuroEyes International Eye Clinic Limited's next confirmed earnings release is scheduled for March 31, 2027.

As of December 31, 2025, EuroEyes International Eye Clinic Limited has 319.50M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, EuroEyes International Eye Clinic Limited maintains a current ratio of 2.79, meaning it holds 2.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 23, 2026, EuroEyes International Eye Clinic Limited's stock has declined approximately 31.61% over the past 52 weeks. The 50-day moving average sits at 2.47, while the 200-day moving average is 2.72.

As of December 31, 2025, EuroEyes International Eye Clinic Limited holds 695.54M in cash and equivalents against 410.19M in total debt, resulting in a net debt position of -695.23M. Total book value stands at 1.25B, with working capital of 498.26M providing operational flexibility.